Literature DB >> 11705908

Induction of epithelial cell death including apoptosis by enteropathogenic Escherichia coli expressing bundle-forming pili.

M Abul-Milh1, Y Wu, B Lau, C A Lingwood, D Barnett Foster.   

Abstract

Infection with enteropathogenic Escherichia coli (EPEC) is a major cause of severe infantile diarrhea, particularly in parts of the developing world. The bundle-forming pilus (BFP) of EPEC is an established virulence factor encoded on the EPEC adherence factor plasmid (EAF) and has been implicated in both localized adherence to host cells and bacterial autoaggregation. We investigated the role of BFP in the ability of EPEC binding to kill host epithelial cells. BFP-expressing strains killed all three cell lines tested, comprising HEp-2 (laryngeal), HeLa (cervical), and Caco-2 (colonic) cells. Analysis of phosphatidylserine expression, internucleosomal cleavage of host cell DNA, and morphological changes detected by electron microscopy indicated evidence of apoptosis. The extent of cell death was significantly greater for BFP-expressing strains, including E2348/69, a wild-type clinical isolate, as well as for a laboratory strain, HB101, transformed with a bfp-carrying plasmid. Strains which did not express BFP induced significantly less cell death, including a bfpA disruptional mutant of E2348/69, EAF plasmid-cured E2348/69, HB101, and HB101 complemented with the locus of enterocyte effacement pathogenicity island. These results indicate a direct correlation between BFP expression and induction of cell death, including apoptosis, an event which may involve the targeting of host cell membrane phosphatidylethanolamine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11705908      PMCID: PMC98822          DOI: 10.1128/IAI.69.12.7356-7364.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Role of EspF in host cell death induced by enteropathogenic Escherichia coli.

Authors:  J K Crane; B P McNamara; M S Donnenberg
Journal:  Cell Microbiol       Date:  2001-04       Impact factor: 3.715

2.  Phosphatidylethanolamine recognition promotes enteropathogenic E. coli and enterohemorrhagic E. coli host cell attachment.

Authors:  D Barnett Foster; D Philpott; M Abul-Milh; M Huesca; P M Sherman; C A Lingwood
Journal:  Microb Pathog       Date:  1999-11       Impact factor: 3.738

3.  Enteropathogenic Escherichia coli virulence factor bundle-forming pilus has a binding specificity for phosphatidylethanolamine.

Authors:  C Khursigara; M Abul-Milh; B Lau; J A Girón; C A Lingwood; D E Barnett Foster
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

4.  Influence of ether linkage on the lamellar to hexagonal phase transition of ethanolamine phospholipids.

Authors:  J M Boggs; D Stamp; D W Hughes; C M Deber
Journal:  Biochemistry       Date:  1981-09-29       Impact factor: 3.162

5.  Enterohemorrhagic Escherichia coli induces apoptosis which augments bacterial binding and phosphatidylethanolamine exposure on the plasma membrane outer leaflet.

Authors:  D Barnett Foster; M Abul-Milh; M Huesca; C A Lingwood
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

6.  The locus of enterocyte effacement (LEE)-encoded regulator controls expression of both LEE- and non-LEE-encoded virulence factors in enteropathogenic and enterohemorrhagic Escherichia coli.

Authors:  S J Elliott; V Sperandio; J A Girón; S Shin; J L Mellies; L Wainwright; S W Hutcheson; T K McDaniel; J B Kaper
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

Review 7.  Lipid polymorphism and the functional roles of lipids in biological membranes.

Authors:  P R Cullis; B de Kruijff
Journal:  Biochim Biophys Acta       Date:  1979-12-20

8.  An ultrastructural study of enteropathogenic Escherichia coli infection in human infants.

Authors:  R J Rothbaum; J C Partin; K Saalfield; A J McAdams
Journal:  Ultrastruct Pathol       Date:  1983-06       Impact factor: 1.094

9.  Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive.

Authors:  M M Levine; E J Bergquist; D R Nalin; D H Waterman; R B Hornick; C R Young; S Sotman
Journal:  Lancet       Date:  1978-05-27       Impact factor: 79.321

10.  Phosphatidylethanolamine and sarcolemmal damage during ischemia or metabolic inhibition of heart myocytes.

Authors:  J A Post; J J Bijvelt; A J Verkleij
Journal:  Am J Physiol       Date:  1995-02
View more
  19 in total

1.  Temporal expression of enteropathogenic Escherichia coli virulence genes in an in vitro model of infection.

Authors:  Laura Q Leverton; James B Kaper
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

2.  Nocardia asteroides strain GUH-2 induces proteasome inhibition and apoptotic death of cultured cells.

Authors:  Daniel P Barry; Blaine L Beaman
Journal:  Res Microbiol       Date:  2006-12-15       Impact factor: 3.992

3.  The enteropathogenic Escherichia coli effector Cif induces delayed apoptosis in epithelial cells.

Authors:  Ascel Samba-Louaka; Jean-Philippe Nougayrède; Claude Watrin; Eric Oswald; Frédéric Taieb
Journal:  Infect Immun       Date:  2009-09-28       Impact factor: 3.441

4.  EspC promotes epithelial cell detachment by enteropathogenic Escherichia coli via sequential cleavages of a cytoskeletal protein and then focal adhesion proteins.

Authors:  Fernando Navarro-Garcia; Antonio Serapio-Palacios; Jorge E Vidal; M Isabel Salazar; Gabriela Tapia-Pastrana
Journal:  Infect Immun       Date:  2014-03-18       Impact factor: 3.441

5.  Enteropathogenic Escherichia coli infection triggers host phospholipid metabolism perturbations.

Authors:  Y Wu; B Lau; S Smith; K Troyan; D E Barnett Foster
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

6.  NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection.

Authors:  Cordula Hemrajani; Cedric N Berger; Keith S Robinson; Olivier Marchès; Aurelie Mousnier; Gad Frankel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-26       Impact factor: 11.205

7.  The enteropathogenic Escherichia coli-secreted protein EspZ inhibits host cell apoptosis.

Authors:  Jennifer Lising Roxas; John Scott Wilbur; Xiangfeng Zhang; Giovanna Martinez; Gayatri Vedantam; V K Viswanathan
Journal:  Infect Immun       Date:  2012-08-20       Impact factor: 3.441

8.  Enteropathogenic Escherichia coli subverts phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate upon epithelial cell infection.

Authors:  Hagit Sason; Michal Milgrom; Aryeh M Weiss; Naomi Melamed-Book; Tamas Balla; Sergio Grinstein; Steffen Backert; Ilan Rosenshine; Benjamin Aroeti
Journal:  Mol Biol Cell       Date:  2008-11-05       Impact factor: 4.138

9.  Pore-forming Activity of the Escherichia coli Type III Secretion System Protein EspD.

Authors:  Abhishek Chatterjee; Celia Caballero-Franco; Dannika Bakker; Stephanie Totten; Armando Jardim
Journal:  J Biol Chem       Date:  2015-08-31       Impact factor: 5.157

10.  Flagellin of enteropathogenic Escherichia coli stimulates interleukin-8 production in T84 cells.

Authors:  Xin Zhou; Jorge A Girón; Alfredo G Torres; J Adam Crawford; Erasmo Negrete; Stefanie N Vogel; James B Kaper
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.